Stock listing

NASDAQ:CELG Celgene Corporation Stock

Follow Celgene Corporation into a list and get an email when it puts out news.

Last close · NASDAQ:CELG

$108.24 USD

Close on Nov 20, 2019 · No longer trades

Jun 26, 2014 to last close +25.0% · weekly closes, Jun 26, 2014 – Nov 20, 2019
Lowest – highest close
$59.21 – $146.52 USDSince Jun 26, 2014 · lowest Dec 24, 2018 · highest Oct 4, 2017

Delisted NASDAQ:CELG no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CELG
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Celgene Corporation on 6ix

Decks
11 decks · latest Mar 25, 2019

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2019)Merger or acquisition25 slidesMar 25, 2019
Merger or Acquisition (March 2019)Merger or acquisition107 slidesMar 19, 2019
Merger or Acquisition (March 2019)Merger or acquisition46 slidesMar 6, 2019
Merger or Acquisition (February 2019)Merger or acquisition37 slidesFeb 20, 2019
FY2018 Earnings PresentationEarnings54 slidesJan 31, 2019
Merger or Acquisition (January 2019)Merger or acquisition26 slidesJan 3, 2019
Proxy Contest (May 2018)Proxy contest28 slidesMay 18, 2018
Merger or Acquisition (January 2018)Merger or acquisition23 slidesJan 22, 2018
Shareholder Meeting (May 2016)Shareholder meeting19 slidesMay 10, 2016
Merger or Acquisition (July 2015)Merger or acquisition29 slidesJul 15, 2015
All 11 decks
DeckKindSlidesDate
Shareholder Meeting (May 2014)Shareholder meeting21 slidesMay 20, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carrie S. Cox
Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); Organon & Co. (Executive Board Chair · Since at least Jun 2, 2021); Texas Instruments Incorporated (Director · Since at least Jul 28, 2015); Cartesian Therapeutics, Inc. (Director · Nov 20, 2019 – Jan 2, 2025 · Past); electroCore, Inc. (Director · Jun 21, 2018 – Jun 7, 2019 · Past); Cardinal Health, Inc. (Director · Nov 4, 2015 – Nov 9, 2022 · Past)
Director · Jul 1, 2015 – Nov 20, 2019 · Past
Alise Reicin
Other companies: Immatics N.V. (Director · Since at least Mar 18, 2026); Tectonic Therapeutic, Inc. (President and CEO, Director · Since at least Jun 20, 2024); Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Q32 Bio Inc. (Director · Jul 11, 2019 – Jun 14, 2023 · Past)
PRES., GLOBAL CLINICAL DEV. · Nov 1, 2018 – Nov 20, 2019 · Past
Hans Bishop
Other companies: Sana Biotechnology, Inc. (Chairman · Since at least Feb 3, 2021); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Agilent Technologies, Inc. (Director · Jul 18, 2017 – Mar 15, 2024 · Past); Juno Therapeutics Inc (CEO & President, Director · Jun 9, 2016 – Mar 5, 2018 · Past)
Director · Apr 18, 2018 – Nov 20, 2019 · Past
John H. Weiland
Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); Cardinal Health, Inc. (Director · Sep 1, 2019 – Nov 11, 2021 · Past); West Pharmaceutical Services, Inc. (Director · Jun 30, 2015 – May 1, 2018 · Past)
Director · Feb 13, 2018 – Nov 20, 2019 · Past
Julia A. Haller
Other companies: Outlook Therapeutics, Inc. (Director · Since at least Aug 11, 2022); Bristol-Myers Squibb Company (Ophthalmologist-in-Chief, Wills Eye Hospital · Since at least Nov 20, 2019); Hyperion DeFi, Inc. (Director · Mar 31, 2021 – Jun 16, 2022 · Past)
Director · Oct 15, 2015 – Nov 20, 2019 · Past
Mark J Alles
Other companies: BioMarin Pharmaceutical Inc. (Director · Jan 1, 2022 – May 23, 2023 · Past); Turning Point Therapeutics Inc (Director · May 24, 2021 – Aug 17, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Dec 19, 2019 – Sep 16, 2023 · Past)
CEO, CHAIRMAN OF BOARD, Director · Feb 15, 2012 – Nov 20, 2019 · Past
Nadim Ahmed
Other companies: Disc Medicine, Inc. (Director · Since at least Jul 14, 2025); Cullinan Therapeutics, Inc. (President and CEO, Director · Since at least Oct 18, 2021); Bristol-Myers Squibb Company (EVP and President, Hematology · Nov 20, 2019 – Dec 31, 2020 · Past)
PRES., GLOBAL HEM. AND ONC. · Jun 13, 2018 – Nov 20, 2019 · Past
Jonathan Biller
Other companies: Vertex Pharmaceuticals Incorporated (EVP and Chief Legal Officer · Since at least Sep 19, 2022); Agios Pharmaceuticals, Inc. (Chief Financial Officer · Dec 3, 2019 – Mar 1, 2022 · Past)
EVP AND GENERAL COUNSEL · Jul 3, 2018 – Nov 20, 2019 · Past
Lawrence V SteinSee Remarks · Nov 26, 2012 – May 14, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Celgene Corporation.